In the European medical devices industry, there were 46 M&A deals announced in Q2 2023, worth a total value of $201.9m, according to GlobalData’s Deals Database. The $69.8m minority acquisition of biocorp production by novo nordisk was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity in Europe decreased by 58% in Q2 2023 compared with the previous quarter’s total of $484.5m and fell by 91% as compared to Q2 2022. Related deal volume remained flat in Q2 2023 versus the previous quarter and was 19% lower than in Q2 2022.
The top-ranked financial advisors supporting these M&A deals in Europe in Q2 2023 were Altor Equity Partners; IMAP; Investec with 2, 2, 2 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Europe Q2 2023 were CMS Legal Services EEIG; Advokatfirman Vinge KB; AKD with 5, 2, 2 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
Smarter leaders trust GlobalData
Premium Insights Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in 2022 -Thematic Intelligence
Premium Insights
The gold standard of business intelligence.
